Bromocriptine may be beneficial in the treatment of early Parkinson's disease
Bromocriptine helps in delaying motor complications and dyskinesias with comparable effects on impairment and disability in those patients that tolerate the drug. Six trials with 850 participants were included. Parkinson's disease is a disabling disease characterised by slowness of movement, trembling (tremors) and stiffness. Currently, the best treatment for Parkinson's disease is levodopa. However, with the number of levodopa treatment years, new disabling fluctuations of movement occur. To overcome this problem, bromocriptine has been tried as an alternative drug. The review of this trials found that bromocriptine may be helpful in delaying such fluctuations of movement problems in patients with Parkinson's disease who can tolerate the drug.